| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |